XML 17 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net loss $ (293,534) $ (1,995,965)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 203,145 387,545
Amortization of deferred financing costs and debt discount 19,364 12,266
Straight-line rent revenue from operating and finance leases (120,674) (127,326)
Stock / Unit-based compensation expense 30,864 30,581
Gain on sale of real estate (4,156) (475,196)
Real estate and other impairment charges, net 167,132 1,441,275
Equity interest real estate impairment 0 410,790
Debt refinancing and unutilized financing costs 3,629 3,677
Tax rate changes and other (10,970) 4,596
Non-cash fair value adjustments 123,370 511,472
Other adjustments (9,724) 12,406
Changes in:    
Interest and rent receivables 8,305 4,147
Other assets 6,756 (18,884)
Accounts payable and accrued expenses (45,719) (20,869)
Deferred revenue (7,085) (11,719)
Net cash provided by operating activities 70,703 168,796
Investing activities    
Cash paid for acquisitions and other related investments (110,089) (105,618)
Net proceeds from sale of real estate 96,961 1,761,661
Proceeds received from sale and repayment of loans receivable 10,049 214,416
Investment in loans receivable (158,974) (392,241)
Construction in progress and other (60,747) (63,535)
Proceeds from sale and return of equity investments 0 11,656
Capital additions and other investments, net (34,069) (199,735)
Net cash (used for) provided by investing activities (256,869) 1,226,604
Financing activities    
Proceeds from term debt 2,512,970 804,188
Payments of term debt (2,252,731) (662,968)
Revolving credit facility, net 171,530 (1,119,312)
Dividends / Distribution paid (144,840) (272,909)
Lease deposits and other obligations to tenants 2,475 (726)
Offering costs (644) 0
Stock / Unit vesting - satisfaction of tax withholdings (1,478) (3,252)
Payment of debt refinancing and deferred financing costs and other financing activities (50,218) (124,595)
Net cash provided by (used for) financing activities 237,064 (1,379,574)
Increase in cash, cash equivalents, and restricted cash for period 50,898 15,826
Effect of exchange rate changes 13,562 7,969
Cash, cash equivalents, and restricted cash at beginning of period 335,173 255,952
Cash, cash equivalents, and restricted cash at end of period 399,633 279,747
Interest paid 393,100 349,608
Supplemental schedule of non-cash financing activities:    
Dividends / Distributions declared, unpaid 48,419 48,172
Cash, cash equivalents, and restricted cash are comprised of the following:    
Cash and cash equivalents at beginning of period 332,335 250,016
Restricted cash, included in Other assets at beginning of period $ 2,838 $ 5,936
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets
Cash, cash equivalents, and restricted cash at beginning of period $ 335,173 $ 255,952
Cash and cash equivalents at end of period 396,577 275,616
Restricted cash, included in Other assets at end of period $ 3,056 $ 4,131
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets
Cash, cash equivalents, and restricted cash at end of period $ 399,633 $ 279,747
MPT Operating Partnership, L.P. [Member]    
Operating activities    
Net loss (293,534) (1,995,965)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 203,145 387,545
Amortization of deferred financing costs and debt discount 19,364 12,266
Straight-line rent revenue and other (120,674) (127,326)
Stock / Unit-based compensation expense 30,864 30,581
Gain on sale of real estate (4,156) (475,196)
Real estate and other impairment charges, net 167,132 1,441,275
Equity interest real estate impairment 0 410,790
Debt refinancing and unutilized financing costs 3,629 3,677
Tax rate changes and other (10,970) 4,596
Non-cash fair value adjustments 123,370 511,472
Other adjustments (9,724) 12,406
Changes in:    
Interest and rent receivables 8,305 4,147
Other assets 6,756 (18,884)
Accounts payable and accrued expenses (45,719) (20,869)
Deferred revenue (7,085) (11,719)
Net cash provided by operating activities 70,703 168,796
Investing activities    
Cash paid for acquisitions and other related investments (110,089) (105,618)
Net proceeds from sale of real estate 96,961 1,761,661
Proceeds received from sale and repayment of loans receivable 10,049 214,416
Investment in loans receivable (158,974) (392,241)
Construction in progress and other (60,747) (63,535)
Proceeds from sale and return of equity investments 0 11,656
Capital additions and other investments, net (34,069) (199,735)
Net cash (used for) provided by investing activities (256,869) 1,226,604
Financing activities    
Proceeds from term debt 2,512,970 804,188
Payments of term debt (2,252,731) (662,968)
Revolving credit facility, net 171,530 (1,119,312)
Dividends / Distribution paid (144,840) (272,909)
Lease deposits and other obligations to tenants 2,475 (726)
Offering costs (644) 0
Stock / Unit vesting - satisfaction of tax withholdings (1,478) (3,252)
Payment of debt refinancing and deferred financing costs and other financing activities (50,218) (124,595)
Net cash provided by (used for) financing activities 237,064 (1,379,574)
Increase in cash, cash equivalents, and restricted cash for period 50,898 15,826
Effect of exchange rate changes 13,562 7,969
Cash, cash equivalents, and restricted cash at beginning of period 335,173 255,952
Cash, cash equivalents, and restricted cash at end of period 399,633 279,747
Interest paid 393,100 349,608
Supplemental schedule of non-cash financing activities:    
Dividends / Distributions declared, unpaid 48,419 48,172
Cash, cash equivalents, and restricted cash are comprised of the following:    
Cash and cash equivalents at beginning of period 332,335 250,016
Restricted cash, included in Other assets at beginning of period $ 2,838 $ 5,936
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets
Cash, cash equivalents, and restricted cash at beginning of period $ 335,173 $ 255,952
Cash and cash equivalents at end of period 396,577 275,616
Restricted cash, included in Other assets at end of period $ 3,056 $ 4,131
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets
Cash, cash equivalents, and restricted cash at end of period $ 399,633 $ 279,747